Eltrombopag is a novel thrombopoietin receptor agonist that has changed the face of treatment of thrombocytopenia, especially in patients with chronic immune thrombocytopenia. The cost of eltrombopag is essentially required to be known by both health care providers and patients, as well as its cost-effectiveness compared to conventional treatments. https://justpaste.it/eelhk